Related Articles
Guillain‑Barre syndrome induced by pembrolizumab and sunitinib: A case report
Discontinuation of anti‑programmed cell death protein 1 immune checkpoint inhibition after complete remission in head and neck squamous cell carcinoma: A case report and literature review
Sorafenib-induced reversible posterior leukoencephalopathy in patients with renal cell carcinoma: A report of two cases
Esophageal squamous cell carcinoma transformed into neuroendocrine carcinoma after neoadjuvant immunochemotherapy: A case report
Pembrolizumab‑induced aseptic meningitis in a patient with non‑small cell lung cancer: A case report and literature review of aseptic meningitis as an immune‑related adverse event